I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Corrigendum: Impact of a TAK-1 inhibitor as a single or as ..:
Daniel Morales-Cano
;
Jose Luis Izquierdo-García
;
Bianca Barreira
...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1228923/full. , 2023
Link:
https://doi.org/10.3389/fphar.2023.1228923
RT Journal T1
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:29cf998c7b394a7c8ccb2b05200ccfd7&Exemplar=1&LAN=DE A1 Daniel Morales-Cano A1 Jose Luis Izquierdo-García A1 Bianca Barreira A1 Sergio Esquivel-Ruiz A1 Maria Callejo A1 Rachele Pandolfi A1 Palmira Villa-Valverde A1 Ignacio Rodríguez A1 Angel Cogolludo A1 Jesus Ruiz-Cabello A1 Francisco Perez-Vizcaino A1 Laura Moreno PB Frontiers Media S.A. YR 2023 K1 pulmonary hypertension K1 antiproliferative K1 metabolomics K1 combination therapy K1 right ventricle K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2023.1228923/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.1228923 DO https://doi.org/10.3389/fphar.2023.1228923 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)